These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8120871)

  • 1. Pyrido[2,3-d]pyrimidine angiotensin II antagonists.
    Ellingboe JW; Antane M; Nguyen TT; Collini MD; Antane S; Bender R; Hartupee D; White V; McCallum J; Park CH
    J Med Chem; 1994 Feb; 37(4):542-50. PubMed ID: 8120871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists.
    Nicolaï E; Curé G; Goyard J; Kirchner M; Teulon JM; Versigny A; Cazes M; Caussade F; Virone-Oddos A; Cloarec A
    J Med Chem; 1994 Jul; 37(15):2371-86. PubMed ID: 8057285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
    J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiallergy activity of 10-oxo-10H-pyrido[1,2-a]thieno[3,2-d]pyrimidines and 10-oxo-10H-pyrido[1,2-a]thieno[3,4-d]pyrimidines.
    Connor DT; Sorenson RJ; Cetenko WA; Kerbleski JJ; Tinney FJ
    J Med Chem; 1984 Apr; 27(4):528-30. PubMed ID: 6142956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M; Provost D; Versigny A; Cloarec A
    Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4239-49. PubMed ID: 8277506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.
    Kubo K; Kohara Y; Imamiya E; Sugiura Y; Inada Y; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jul; 36(15):2182-95. PubMed ID: 8340921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptor.
    Hara M; Kiyama R; Nakajima S; Kawabata T; Kawakami M; Ohtani K; Itazaki K; Fujishita T; Fujimoto M
    Eur J Pharmacol; 1995 Apr; 289(2):267-73. PubMed ID: 7621900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines.
    Hafez HN; Abbas HA; El-Gazzar AR
    Acta Pharm; 2008 Dec; 58(4):359-78. PubMed ID: 19103572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
    Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors.
    Kawano K; Fujishima K; Nagura J; Yasuda S; Shinki ; Hachisu M; Konno F
    Eur J Pharmacol; 1998 Sep; 357(1):33-9. PubMed ID: 9788771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor subtypes mediating spinal cardiovascular effects of angiotensin II in rat using losartan and PD 123319.
    Park PD; Henry JL
    Eur J Pharmacol; 1997 May; 326(2-3):139-45. PubMed ID: 9196266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Profiles of a Highly Potent and Long-Acting Angiotensin II Receptor Antagonist, Fimasartan, in Rats and Dogs after Oral Administration.
    Paik SH; Chi YH; Lee JH; Han HS; Lee KT
    Biol Pharm Bull; 2017; 40(7):992-1001. PubMed ID: 28674263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive activity of 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives.
    Bennett LR; Blankley CJ; Fleming RW; Smith RD; Tessman DK
    J Med Chem; 1981 Apr; 24(4):382-9. PubMed ID: 7265125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
    Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; García-Rafanell J; Forn J
    J Med Chem; 1997 Feb; 40(4):547-58. PubMed ID: 9046346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).
    Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM
    J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC; Christ DD; Timmermans PB
    Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids.
    Kubo K; Kohara Y; Yoshimura Y; Inada Y; Shibouta Y; Furukawa Y; Kato T; Nishikawa K; Naka T
    J Med Chem; 1993 Aug; 36(16):2343-9. PubMed ID: 8360879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.